Over 12 million people in the United States died from all causes between the beginning of January 2020 and August 21, 2023. Over 1.1 million of those deaths were with confirmed or presumed COVID-19.

Vaccine rollout in the United States Finding a safe and effective COVID-19 vaccine was an urgent health priority since the very start of the pandemic. In the United States, the first two vaccines were authorized and recommended for use in December 2020. One has been developed by Massachusetts-based biotech company Moderna, and the number of Moderna COVID-19 vaccines administered in the U.S. was over 250 million. Moderna has also said that its vaccine is effective against the coronavirus variants first identified in the UK and South Africa.

Between January and August 2020, there has been approximately 48.2 thousand deaths in England and Wales with COVID-19 as an underlying cause. As illustrated in the table, the number of deaths as a result of COVID-19 are much higher than from either pneumonia or influenza. There has been over three times the number of deaths from COVID-19 than pneumonia and influenza so far in 2020. The overall number of confirmed COVID-19 cases in the UK can be found here. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Context

New York has presented the most cases compared to all states across the U.S..There have also been critiques regarding how much more unnoticed impact the flu has caused. My dataset allows us to compare whether or not this is true according to the most recent data.

Content

This COVID-19 data is from Kaggle whereas the New York influenza data comes from the U.S. government health data website. I merged the two datasets by county and FIPS code and listed the most recent reports of 2020 COVID-19 cases and deaths alongside the 2019 known influenza cases for comparison.

Acknowledgements

I am thankful to Kaggle and the U.S. government for making the data that made this possible openly available.

Inspiration

This data can be extended to answer the common misconceptions of the scale of the COVID-19 and common flu. My inspiration stems from supporting conclusions with data rather than simply intuition.

I would like my data to help answer how we can make U.S. citizens realize what diseases are most impactful.

As of January 6, 2022, an average of 1,192 people per day have died from COVID-19 in the U.S. since the first case was confirmed in the country on January 20th the year before. On an average day, nearly 8,000 people die from all causes in the United States, based on data from 2019. Based on the latest information, roughly one in seven deaths each day were related to COVID-19 between January 2020 and January 2022. However, there were even days when more than every second death in the U.S. was connected to COVID-19. The daily death toll from the seasonal flu, using preliminary maximum estimates from the 2019-2020 influenza season, stood at an average of around 332 people. We have to keep in mind that a comparison of influenza and COVID-19 is somewhat difficult. COVID-19 cases and deaths are counted continuously since the begin of the pandemic, whereas flue counts are seasonal and often less accurate. Furthermore, during the last two years, COVID-19 more or less 'replaced' the flu, with COVID-19 absorbing potential flu cases. Many countries reported a very weak seasonal flu activity during the COVID-19 pandemic. But it has yet to be seen how the two infectious diseases will develop side by side during the winter season 2021/2022 and in the years to come.

Symptoms and self-isolation COVID-19 and influenza share similar symptoms – a cough, runny nose, and tiredness – and telling the difference between the two can be difficult. If you have minor symptoms, there is no need to seek urgent medical care, but it is recommended that you self-isolate, whereas rules vary from country to country. Additionally, rules depend on someone's vaccination status and infection history. However, if you think you have the disease, a diagnostic test can show if you have an active infection.

Scientists alert to coronavirus mutations The genetic material of the novel coronavirus is RNA, not DNA. Other notable human diseases caused by RNA viruses include SARS, Ebola, and influenza. A continual problem that vaccine developers encounter is that viruses can mutate, and a treatment developed against a certain virus type may not work on a mutated form. The seasonal flu vaccine, for example, is different each year because influenza viruses are frequently mutating, and it is critical that those genetic changes continue to be tracked.

As of May 2, 2023, the outbreak of the coronavirus disease (COVID-19) had spread to almost every country in the world, and more than 6.86 million people had died after contracting the respiratory virus. Over 1.16 million of these deaths occurred in the United States.

Waves of infections Almost every country and territory worldwide have been affected by the COVID-19 disease. At the end of 2021 the virus was once again circulating at very high rates, even in countries with relatively high vaccination rates such as the United States and Germany. As rates of new infections increased, some countries in Europe, like Germany and Austria, tightened restrictions once again, specifically targeting those who were not yet vaccinated. However, by spring 2022, rates of new infections had decreased in many countries and restrictions were once again lifted.

What are the symptoms of the virus? It can take up to 14 days for symptoms of the illness to start being noticed. The most commonly reported symptoms are a fever and a dry cough, leading to shortness of breath. The early symptoms are similar to other common viruses such as the common cold and flu. These illnesses spread more during cold months, but there is no conclusive evidence to suggest that temperature impacts the spread of the SARS-CoV-2 virus. Medical advice should be sought if you are experiencing any of these symptoms.

Age-standardised mortality rates for deaths involving coronavirus (COVID-19), non-COVID-19 deaths and all deaths by vaccination status, broken down by age group.

Among the ten major virus outbreaks in the last 50 years, Marburg ranked first in terms of the fatality rate with 80 percent. In comparison, the recent novel coronavirus, originating from the Chinese city of Wuhan, had an estimated fatality rate of 2.2 percent as of January 31, 2020. Alarming COVID-19 fatality rate in Mexico More than 812,000 people worldwide had died from COVID-19 as of August 24, 2020. Three of the most populous countries in the world have reported particularly large numbers of coronavirus-related deaths: Mexico, Brazil, and the United States. Out of those three nations, Mexico has the highest COVID-19 death rate, with around one in ten confirmed cases resulting in death. The high fatality rate in Mexico indicates that cases may be much higher than reported because testing capacity has been severely stretched. Post-lockdown complacency a real danger In March 2020, each infected person was estimated to transmit the COVID-19 virus to between 1.5 and 3.5 other people, which was a higher infection rate than the seasonal flu. The coronavirus is primarily spread through respiratory droplets, and transmission commonly occurs when people are in close contact. As lockdowns ease around the world, people are being urged not to become complacent; continue to wear face coverings and practice social distancing, which can help to prevent further infections.

Introduction: Respiratory viruses are among the leading causes of disease and death among children. Co-circulation of influenza and SARS-CoV2 can lead to diagnostic and management difficulties given the similarities in the clinical picture.Methods: This is a cohort of all children hospitalized with SARS-CoV2 infection from March to September 3rd 2020, and all children admitted with influenza throughout five flu-seasons (2013–2018) at a pediatric referral hospital. Patients with influenza were identified from the clinical laboratory database. All hospitalized patients with confirmed SARS-CoV2 infection were followed-up prospectively.Results: A total of 295 patients with influenza and 133 with SARS-CoV2 infection were included. The median age was 3.7 years for influenza and 5.3 years for SARS-CoV2. Comorbidities were frequent in both groups, but they were more common in patients with influenza (96.6 vs. 82.7%, p < 0.001). Fever and cough were the most common clinical manifestations in both groups. Rhinorrhea was present in more than half of children with influenza but was infrequent in those with COVID-19 (53.6 vs. 5.8%, p < 0.001). Overall, 6.4% percent of patients with influenza and 7.5% percent of patients with SARS-CoV2 infection died. In-hospital mortality and the need for mechanical ventilation among symptomatic patients were similar between groups in the multivariate analysis.Conclusions: Influenza and COVID-19 have a similar picture in pediatric patients, which makes diagnostic testing necessary for adequate diagnosis and management. Even though most cases of COVID-19 in children are asymptomatic or mild, the risk of death among hospitalized patients with comorbidities may be substantial, especially among infants.

AimTo clarify the high variability in COVID-19-related deaths during the first wave of the pandemic, we conducted a modeling study using publicly available data.Materials and methodsWe used 13 population- and country-specific variables to predict the number of population-standardized COVID-19-related deaths in 43 European countries using generalized linear models: the test-standardized number of SARS-CoV-2-cases, population density, life expectancy, severity of governmental responses, influenza-vaccination coverage in the elderly, vitamin D status, smoking and diabetes prevalence, cardiovascular disease death rate, number of hospital beds, gross domestic product, human development index and percentage of people older than 65 years.ResultsWe found that test-standardized number of SARS-CoV-2-cases and flu vaccination coverage in the elderly were the most important predictors, together with vitamin D status, gross domestic product, population density and government response severity explaining roughly two-thirds of the variation in COVID-19 related deaths. The latter variable was positively, but only weakly associated with the outcome, i.e., deaths were higher in countries with more severe government response. Higher flu vaccination coverage and low vitamin D status were associated with more COVID-19 related deaths. Most other predictors appeared to be negligible.ConclusionAdequate vitamin D levels are important, while flu-vaccination in the elderly and stronger government response were putative aggravating factors of COVID-19 related deaths. These results may inform protection strategies against future infectious disease outbreaks.

The COVID-19 dashboard includes data on city/town COVID-19 activity, confirmed and probable cases of COVID-19, confirmed and probable deaths related to COVID-19, and the demographic characteristics of cases and deaths.

Context

The 2009 swine flu pandemic was an influenza pandemic that lasted for about 19 months, from January 2009 to August 2010, and the second of two pandemics involving H1N1 influenza virus.

Content

1. data.csv - contains day by day country wise no. of cases & deaths from 4th April to 6th July 2009

Note

• Although the pandemic went on for more than 2 years the data is only from 24th April 2009 to 6th July 2009.
• Because the countries were no longer required to test and report individual cases from 6th July 2009.
• So that day by day data from 6th July 2009 is not available.

Acknowledgements / Data Source

https://www.who.int/csr/disease/swineflu/updates/en/

Collection methodology

https://github.com/imdevskp/h1n1_data_webscrapping

Cover Photo

Photo from CDC Blog https://blogs.cdc.gov/publichealthmatters/2019/04/h1n1/

Similar Datasets

• COVID-19 - https://www.kaggle.com/imdevskp/corona-virus-report
• MERS - https://www.kaggle.com/imdevskp/mers-outbreak-dataset-20122019
• Ebola Western Africa 2014 Outbreak - https://www.kaggle.com/imdevskp/ebola-outbreak-20142016-complete-dataset
• H1N1 | Swine Flu 2009 Pandemic Dataset - https://www.kaggle.com/imdevskp/h1n1-swine-flu-2009-pandemic-dataset
• SARS 2003 Pandemic - https://www.kaggle.com/imdevskp/sars-outbreak-2003-complete-dataset
• HIV AIDS - https://www.kaggle.com/imdevskp/hiv-aids-dataset

Rank, number of deaths, percentage of deaths, and age-specific mortality rates for the leading causes of death, by age group and sex, 2000 to most recent year.

For the week ending August 29, 2025, weekly deaths in England and Wales were 985 below the number expected, compared with 855 below what was expected in the previous week. In late 2022 and through early 2023, excess deaths were elevated for a number of weeks, with the excess deaths figure for the week ending January 13, 2023, the highest since February 2021. In the middle of April 2020, at the height of the COVID-19 pandemic, there were almost 12,000 excess deaths a week recorded in England and Wales. It was not until two months later, in the week ending June 19, 2020, that the number of deaths began to be lower than the five-year average for the corresponding week. Most deaths since 1918 in 2020 In 2020, there were 689,629 deaths in the United Kingdom, making that year the deadliest since 1918, at the height of the Spanish influenza pandemic. As seen in the excess death figures, April 2020 was by far the worst month in terms of deaths during the pandemic. The weekly number of deaths for weeks 16 and 17 of that year were 22,351, and 21,997 respectively. Although the number of deaths fell to more usual levels for the rest of that year, a winter wave of the disease led to a high number of deaths in January 2021, with 18,676 deaths recorded in the fourth week of that year. For the whole of 2021, there were 667,479 deaths in the UK, 22,150 fewer than in 2020. Life expectancy in the UK goes into reverse In 2022, life expectancy at birth for women in the UK was 82.6 years, while for men it was 78.6 years. This was the lowest life expectancy in the country for ten years, and came after life expectancy improvements stalled throughout the 2010s, and then declined from 2020 onwards. There is also quite a significant regional difference in life expectancy in the UK. In the London borough of Kensington and Chelsea, for example, the life expectancy for men was 81.5 years, and 86.5 years for women. By contrast, in Blackpool, in North West England, male life expectancy was just 73.1 years, while for women, life expectancy was lowest in Glasgow, at 78 years.

How did Brazil become a global epicenter of the outbreak? After seeming to ease, is the virus making a comeback?

A world leader in infections and deaths.

Latin America became an epicenter of the coronavirus pandemic in May, driven by Brazil’s ballooning caseload. Ten months after its first known case, Brazil has had more than 7.9 million cases and over 200,000 deaths.

In early June, Brazil began averaging about 1,000 deaths per day from Covid-19, joining the United States — and later India — as the countries with the world’s largest death tolls.

This dataset contains information about COVID-19 in Brazil extracted on the date 16/06/2021. It is the most updated dataset available about Covid in Brazil

Features:

🔍 date: date that the data was collected. format YYYY-MM-DD.
🔍 state: Abbreviation for States. Example: SP
🔍 city: Name of the city (if the value is NaN, they are referring to the State, not the city)
🔍 place_type: Can be City or State
🔍 order_for_place: Number that identifies the registering order for this location. The line that refers to the first log is going to be shown as 1, and the following information will start the count as an index.
🔍 is_last: Show if the line was the last update from that place, can be True or False
🔍 city_ibge_code: IBGE Code from the location
🔍confirmed: Number of confirmed cases.
🔍deaths: Number of deaths.
🔍estimated_population: Estimated population for this city/state in 2020. Data from IBGE
🔍estimated_population_2019: Estimated population for this city/state in 2019. Data from IBGE.
🔍confirmed_per_100k_inhabitants: Number of confirmed cases per 100.000 habitants (based on estimated_population).
🔍death_rate: Death rate (deaths / confirmed cases).

Acknowledgements

This dataset was downloaded from the URL bello. Thanks, Brasil.IO! Their main goal is to make all Brazilian data available to the public DATASET URL: https://brasil.io/dataset/covid19/files/ Cities map file https://geoftp.ibge.gov.br/organizacao_do_territorio/malhas_territoriais/malhas_municipais/municipio_2020/Brasil/BR/

Similar Datasets

COVID-19 - https://www.kaggle.com/rafaelherrero/covid19-brazil-full-cases-17062021 COVID-19 - https://www.kaggle.com/imdevskp/corona-virus-report MERS - https://www.kaggle.com/imdevskp/mers-outbreak-dataset-20122019 Ebola Western Africa 2014 Outbreak - https://www.kaggle.com/imdevskp/ebola-outbreak-20142016-complete-dataset H1N1 | Swine Flu 2009 Pandemic Dataset - https://www.kaggle.com/imdevskp/h1n1-swine-flu-2009-pandemic-dataset SARS 2003 Pandemic - https://www.kaggle.com/imdevskp/sars-outbreak-2003-complete-dataset HIV AIDS - https://www.kaggle.com/imdevskp/hiv-aids-dataset

The burden of influenza in the United States can vary from year to year depending on which viruses are circulating, how many people receive an influenza vaccination, and how effective the vaccination is in that particular year. During the 2023-2024 flu season, around 28,000 people lost their lives to the disease. Although most people recover from influenza without needing medical care, the disease can be deadly among young children, the elderly, and those with weakened immune systems or chronic illnesses. Deaths due to influenza Even though most people recover from influenza without medical care, influenza and pneumonia can be deadly, especially for older people and those with certain preexisting conditions. Influenza is a common cause of pneumonia and although most cases of influenza do not develop into pneumonia, those that do are often more severe and more deadly. Deaths due to influenza are most common among the elderly, with a mortality rate of around 32 per 100,000 population during the 2023-2024 flu season. In comparison, the mortality rate for those aged 50 to 64 years was 9.1 per 100,000 population. Flu vaccinations The most effective way to prevent influenza is to receive an annual influenza vaccination. These vaccines have proven to be safe and are usually cheap and easily accessible. Nevertheless, every year a large share of the population in the United States still fails to get vaccinated against influenza. For example, in the 2022-2023 flu season, only 35 percent of those aged 18 to 49 years received a flu vaccination. Unsurprisingly, children and the elderly are the most likely to get vaccinated. It is estimated that during the 2022-2023 flu season, vaccinations prevented over 929 thousand influenza cases among children aged 6 months to 4 years.

Counts of SARS-CoV-2-related deaths have been key numbers for justifying severe political, social and economical measures imposed by authorities world-wide. A particular focus thereby was the concomitant excess mortality (EM), i.e. fatalities above the expected all-cause mortality (AM). Recent studies, inter alia by the WHO, estimated the SARS-CoV-2-related EM in Germany between 2020 and 2021 as high as 200 000. In this study, we attempt to scrutinize these numbers by putting them into the context of German AM since the year 2000. We propose two straightforward, age-cohort-dependent models to estimate German AM for the ‘Corona pandemic’ years, as well as the corresponding flu seasons, out of historic data. For Germany, we find overall negative EM of about due to rather than with CoViD-19; an analysis not provided by the appropriate authority, the RKI. Through 2020 and 2021 combined, our due estimate is at no more than 59 500. Varying NAA test strategies heavily obscured SARS-CoV-2-related EM, particularly within the second year of the proclaimed pandemic. We compensated changes in test strategies by assuming that age-cohort-specific NAA-conditional mortality rates during the first pandemic year reflected a SARS-CoV-2-characteristic constants.

Among infectious diseases that were recorded in Japan, the highest number of deaths was caused by the coronavirus disease (COVID-19), which amounted to ****** deaths in 2023. The number of deaths from infectious enterogastritis followed with around ***** cases.  Seasonal influenza in Japan  The influenza season in Japan typically begins in November or December and reaches its peak in the first two months of the following year. The number of deaths caused by seasonal flu in Japan has been increasing in recent years. Since 2010, more than ** million influenza vaccine units have been supplied in the country annually. Citizens aged 60 years and over are eligible to receive free periodic influenza vaccines from their municipality. Around ** million elderly have received such a free vaccination yearly. Receding flu infections during COVID-19 During the COVID-19 pandemic, a partial decrease in monthly flu patients was observed in Japan. This development was partially attributed to a phenomenon called viral interference, making people less susceptible to influenza viruses in areas where the coronavirus is predominant. In case of an infection with the novel virus, infected cells secrete so-called interferon proteins, which block other viruses. Nationwide preventive measures such as face masks, home office implementation, and regulations of gastronomy opening hours had also shown a positive influence on reducing infection numbers of diseases like influenza.